Last Updated : 25th July 2016
What do we do in complete responses post neoadjuvant chemoradiotherapy in rectal cancers?
Dr Mark Saunders FRCR PhD, Consultant Clinical Oncologist, The Christie NHS Trust, Manchester, UK
Carbon Ion Radiotherapy
Prof Naruhiro Matsufuji PhD, QST-National Institute of Radiological Sciences, Japan
Prof David Bradley, PhD, University of Surrey, UK
Breast surgery post neoadjuvant treatment : Mastectomy or Breast Conserving surgery?
Prof Dato’ Yip Cheng Har FRCS, Consultant Breast Surgeon, Sime Darby Medical Centre, Kuala Lumpur, Malaysia
CROSS Trial and beyond : The hallmarks of multimodality therapy in oesophageal cancer
Dr Tom Richards FRCR PhD, Consultant Clinical Oncologist, Barts Health NHS Trust, London, UK
Experiences in Stereotactic Ablative Body Radiotherapy (SABR) in Non Small Cell Lung Cancer : An Alternative to Surgery
Dr Jeremy Ruben FRANZCR, Consultant Radiation Oncologist, William Buckland Radiotherapy Centre, Melbourne, Australia
Concurrent chemoradiotherapy followed by surgery in Pancoast’s tumour : An example of multimodality therapy
Dr Francis Ho Cho Hao FRANZCR, Consultant Radiation Oncologist, National University Cancer Institute, Singapore
Advances in Radiotherapy Treatment Planning
Dr Supriyanto A. Pawiro PhD, Department of Physics, FMIPA, Universitas Indonesia
Optimising treatment in potentially resectable liver metastasis in colorectal cancer
Assoc Prof Dato’ Dr Fuad Ismail FFRRCS FRCR, Consultant Clinical Oncologist, Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur.
Cyberknife and Challenging Lesions
Dato’ Dr Ibrahim Wahid, Consultant Clinical Oncologist, Beacon Specialist Hospital, Kuala Lumpur, Malaysia
Surgery post neoadjuvant therapy in rectal cancers : The challenges
Prof Mr Ismail Sagap, Consultant Colorectal Surgeon, Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur.
Role of immunotherapy in multimodality treatments
Dr Tho Lye Mun FRCR PhD, Consultant Clinical Oncologist, Beacon Specialist Centre, Kuala Lumpur, Malaysia
Oesophagectomy post neoadjuvant therapy
Mr Mohamad Shukri Jahit, Consultant Upper GI Surgeon, Hospital Sungai Buloh
Role of palliative nephrectomy in the era of systemic tyrosine kinase inhibitors.
Dr A Radzi, CEO & Consultant Clinical Oncologist, Integrated Oncology Centre, Johor Bahru, Malaysia
How radical can and should we go in head and neck surgery?
Dr Zulkifli Yusof, Consultant ENT Surgeon and Head of Department, Hospital Sultanah Bahiyah, Alor Setar, Malaysia
How p16 influences radiotherapy decisions in Oropharyngeal Cancers?
Dr Beng Yap, Consultant Clinical Oncologist, Sime Darby Medical Centre, Kuala Lumpur, Malaysia
Image Guided Radiotherapy (IGRT) in Head and Neck Cancers
Dr Hafiz Mohd Zin, Senior Lecturer/Medical Physicist, AMDI, Universiti Sains Malaysia
: count(): Parameter must be an array or an object that implements Countable in /homepages/20/d554519979/htdocs/clickandbuilds/AMDI1stInternationalOncologySymposiumand10thInternationalSeminaronMedicalPhysics/wp-includes/class-wp-comment-query.php
on line 399